financetom
Business
financetom
/
Business
/
Market Chatter: BlackRock Seeks Partial Redemption From Jefferies Fund Exposed to Bankrupt First Brands
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Market Chatter: BlackRock Seeks Partial Redemption From Jefferies Fund Exposed to Bankrupt First Brands
Oct 8, 2025 1:12 PM

03:41 PM EDT, 10/08/2025 (MT Newswires) -- BlackRock ( BLK ) has asked to withdraw part of its investment from a Jefferies (JEF) fund with significant exposure to the trade debt of bankrupt auto parts maker First Brands Group, Bloomberg reported Wednesday, citing people familiar with the matter.

Other investors, including the Texas Treasury Safekeeping Trust, also sought partial redemptions from Point Bonita Capital, a Jefferies unit managing about $3 billion in trade-finance assets, according to the report.

The fund held roughly $715 million in receivables owed to First Brands, Jefferies said.

Payments from First Brands stopped on Sept. 15, ahead of its Sept. 28 bankruptcy filing. Jefferies said its unit Leucadia holds a 5.9% stake in Point Bonita, meaning most losses would fall on outside investors.

BlackRock ( BLK ) and Jefferies did not immediately respond to MT Newswires' request for comment on the matter.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Price: 1166.99, Change: +0.76, Percent Change: +0.07

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Humacyte Partners With Trestle Biotherapeutics on Bioengineered Kidney Research
Humacyte Partners With Trestle Biotherapeutics on Bioengineered Kidney Research
Mar 6, 2025
09:15 AM EST, 03/06/2025 (MT Newswires) -- Humacyte ( HUMA ) , a commercial-stage company, will collaborate with preclinical-stage firm Trestle Biotherapeutics to explore technology synergies for bioengineering vascularized organs for transplantation, Trestle Biotherapeutics said Thursday. Trestle Bio said the research allows both companies to expand their own R&D programs while looking into the interaction of Trestle Bio's biofabricated human...
BRIEF-Advanced Biomed Announces Pricing Of Initial Public Offering
BRIEF-Advanced Biomed Announces Pricing Of Initial Public Offering
Mar 6, 2025
March 6 (Reuters) - Advanced Biomed Inc: * ADVANCED BIOMED INC. ANNOUNCES PRICING OF INITIAL PUBLIC OFFERING * ADVANCED BIOMED: PRICING OF IPO OF 1.6 MILLION SHARES AT $4.00 PER SHARE Source text: Further company coverage: ([email protected]) ...
BRIEF-Willdan Strengthens Electrical Engineering Capabilities With The Acquisition Of APG
BRIEF-Willdan Strengthens Electrical Engineering Capabilities With The Acquisition Of APG
Mar 6, 2025
March 6 (Reuters) - Willdan Group Inc ( WLDN ): * WILLDAN STRENGTHENS ELECTRICAL ENGINEERING CAPABILITIES WITH THE ACQUISITION OF APG * WILLDAN GROUP INC ( WLDN ): TRANSACTION TERMS WERE NOT DISCLOSED * WILLDAN GROUP INC ( WLDN ) - ACQUIRES ALTERNATIVE POWER GENERATION IN STOCK PURCHASE Source text: Further company coverage: ([email protected]) ...
Teladoc, LifeMD tie up with Lilly's pharmacy partner to offer Zepbound
Teladoc, LifeMD tie up with Lilly's pharmacy partner to offer Zepbound
Mar 6, 2025
March 6 (Reuters) - Telehealth firms Teladoc and LifeMD ( LFMD ) said on Thursday they had signed an agreement with Gifthealth, the pharmacy partner of Eli Lilly's ( LLY ) direct-to-consumer site, LillyDirect, to offer patients the weight-loss drug, Zepbound. Telehealth companies have previously offered compounded versions of weight-loss treatments when the drugs were in shortage. However, with the...
Copyright 2023-2025 - www.financetom.com All Rights Reserved